Skip to main content
. 2013 Jul 29;288(39):27972–27985. doi: 10.1074/jbc.M113.477547

TABLE 3.

Effect of PK activity on PrPSc glycoform ratio

Values are expressed as relative percentage ± S.D. of diglycosylated (D), monoglycosylated (M), and unglycosylated (U) PrPSc based on densitometric analyses of immunoblots probed with mAb 3F4. Statistically significant comparisons (Student's t test or Mann-Whitney rank sum test) included diglycosylated PrPSc in VV1 (p < 0.01).

CJD type Lowest tested PK activitya
PK activity at ED50b
D M U D M U
VV1 21.0 ± 1.6 40.0 ± 4.0 39.0 ± 2.4 17.5 ± 1.0 40.7 ± 3.1 41.8 ± 3.4
MM1 26.1 ± 1.5 49.0 ± 1.6 24.9 ± 2.3 25.9 ± 1.1 47.5 ± 2.4 26.6 ± 1.3
MM 2T 22.0 ± 0.4 44.5 ± 2.3 33.5 ± 1.9 20.3 ± 0.8 44.0 ± 0.5 35.7 ± 0.4
MM 2C 25.4 ± 2.0 42.0 ± 0.5 32.6 ± 1.9 24.6 ± 1.3 43.3 ± 2.4 32.1 ± 2.8
MV 2K 27.9 ± 1.9 40.6 ± 2.0 31.6 ± 0.5 27.5 ± 2.0 39.1 ± 0.8 33.4 ± 1.5
VV2 39.1 ± 5.2 41.9 ± 1.5 19.0 ± 5.1 38.7 ± 3.9 41.2 ± 1.8 20.1 ± 3.5
vCJD 49.1 ± 0.7 34.5 ± 2.3 16.4 ± 1.6 47.0 ± 1.6 35.4 ± 1.9 17.7 ± 0.4

a Activity was 0.004 unit/ml for VV1 and MM 2T and 0.0315 unit/ml for all other subtypes.

b Activity was 0.0625 unit/ml for VV1, 0.125 unit/ml for MM1, 0.25 unit/ml for MM 2T and MM 2C, 2 units/ml for MV 2K, 5 units/ml for VV2, and 10 units/ml for vCJD.